Literature DB >> 6282437

The immunohistochemical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors.

Y A Teramoto, R Meriani, D Wunderlich, J Schlom.   

Abstract

Human monoclonal antibodies have been generated following the fusion of human lymphocytes (obtained from axillary lymph nodes of mastectomy patients) with a murine nonimmunoglobulin secreting myeloma cell line. We report a detailed analysis of the reactivity of a human IgM monoclonal antibody secreted by one of these double cloned hybridoma cell lines. Tissue sections of both malignant and benign human mammary tumors, as well as apparently normal tissues, were tested using the immunoperoxidase technique and the human monoclonal antibody. Eighty-one per cent (54/67) of primary malignant mammary tumors, 100% (20/20) of metastatic breast lesions, and 14% (3/22) of benign breast lesions reacted positively with a moderate for strong intensity. The per cent of mammary carcinoma cells that stained and the pattern of staining varied among different tumor samples. While reactivity was observed with selected carcinomas of nonbreast origin, little or no reactivity was observed with apparently normal human tissues including normal mammary epithelium. The antibody reactivity observed was shown to be clearly distinct from those of both anti-T and anticarcinoembryonic antigen sera.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282437     DOI: 10.1002/1097-0142(19820715)50:2<241::aid-cncr2820500214>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Localization of a membrane glycoprotein in benign fibrocystic disease and infiltrating duct carcinomas of the human breast with the use of a monoclonal antibody to guinea pig milk fat globule membrane.

Authors:  D E Greenwalt; V G Johnson; F P Kuhajda; J C Eggleston; I H Mather
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

2.  Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast.

Authors:  T Ito; S Saga; S Nagayoshi; M Imai; A Aoyama; T Yokoi; M Hoshino
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma.

Authors:  R Mariani-Costantini; M I Colnaghi; F Leoni; S Mènard; S Cerasoli; F Rilke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.

Authors:  R Mariani-Costantini; P Barbanti; M I Colnaghi; S Ménard; C Clemente; F Rilke
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

5.  Tumour localisation by human monoclonal antibodies.

Authors:  K Sikora; T Alderson; A Nethersell; H Smedley
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

6.  The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.

Authors:  H R Zenklusen; C Stähli; F Gudat; J von Overbeck; J Rolink; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.